Company Overview and News

Cradle Resources attracts $2.9 million for niobium project in Tanzania

Cradle Resources Ltd (ASX:CXX) is raising $2.9 million via the placement of shares at $0.12 each to institutional and sophisticated investors.
Upvote Downvote

Cradle Resources to expand portfolio via acquisition

Cradle Resources Ltd (ASX:CXX) is readying to reveal details of a newly acquired resource project, and the ASX has granted a trading halt to prepare.
Upvote Downvote

UPDATE 1-Investors wary as Tanzania moves to assert more control over mines

2017-09-25 reuters
NAIROBI/LONDON (Reuters) - New laws and a crackdown on mining firms in Tanzania has slowed fresh investment in what has long been seen as one of Africa’s brightest mining prospects as companies assess the consequences of government efforts to claim a bigger slice of the pie.
Upvote Downvote

Investors wary as Tanzania moves to assert more control over mines

2017-09-24 reuters
NAIROBI/LONDON (Reuters) - New laws and a crackdown on mining firms in Tanzania has slowed fresh investment in what has long been seen as one of Africa’s brightest mining prospects as companies assess the consequences of government efforts to claim a bigger slice of the pie.
Upvote Downvote

Tanzania players continue share price slide

Kibaran Resources and Black Rock Mining are the latest Perth-based explorers with operations in Tanzania to come out of a trading halt since legislative changes in the African country were announced.
Upvote Downvote

Tanzanian explorers smashed on ASX

Exploration companies Orecorp, Cradle Resources and Graphex Mining have been pummelled on the ASX following the Tanzanian government’s approved changes to mining and exporting laws late last week.
Upvote Downvote

Juniors come to terms with changes in Tanzania

The Tanzanian government has revealed the full slate of legislative changes which will affect the companies behind the mining and export of precious metals in the country, some of which are based in Perth.
Upvote Downvote

Cradle Resources Ltd enters an ASX trading halt

Cradle Resources Ltd (ASX:CXX) has been granted a trading halt by the ASX, pending details of draft changes to mining legislation proposed by the Tanzanian government.
Upvote Downvote

Cradle to accept $55m takeover offer

Niobium explorer Cradle Resources has recommended shareholders accept a takeover offer from joint venture partner Tremont Investments, which values the target at $55 million.
Upvote Downvote

Cradle Resources in an ASX trading halt

Cradle Resources (ASX:CXX) has been granted a trading halt by the ASX, pending details on a potential change of control transaction.
Upvote Downvote

Annual Financial Report

2016-09-26 londonstockexchange
Mr Ian Middlemas                  Chairman Mr Benjamin Stoikovich        Director and CEO Ms Carmel Daniele               Non-Executive Director Mr Thomas Todd                    Non-Executive Director Mr Mark Pearce                       Non-Executive Director Mr Todd Hannigan                 Alternate Director
Upvote Downvote

Annual Financial Report

2016-09-26 londonstockexchange
Unit 1C, Princes House 38 Jermyn Street London SW1Y 6DN United Kingdom Telephone:   +44 207 478 3900
Upvote Downvote

Middlemas to chair Cradle

Prominent businessman Ian Middlemas has replaced Craig Burton as chairman of niobium hopeful Cradle Resources, adding to a lengthy list of local company boards he chairs.
Upvote Downvote

Cradle, Ardiden raise funds

Local explorers Cradle Resources and Ardiden have announced plans to raise a combined $5 million to fund ongoing work at their respective projects.
Upvote Downvote

Commodity no one knows about but everybody wants to buy

2016-05-18 themalaymailonline
A lump of gray shining niobium crystals with hexagonal facetting. ― Wikipedia picNEW YORK, May 18 ― The world’s mines and steel plants got so devalued during the commodity slump that some were just given away by owners struggling to cut losses or debt. But there’s at least one metal that’s been attracting a lot of attention.
Upvote Downvote

Related Articles

LPCN: Lipocine Inc Analysis and Research Report

11h - Asif

Overview Lipocine is a specialty pharmaceutical company focused on applying its oral drug delivery technology for the development of pharmaceutical products in the area of men’s and women’s health. The company's proprietary delivery technologies are designed to improve patient compliance and safety through orally available treatment options. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Lipocine has a portfolio of proprietary product candidates designed to produce favorable pharmacokinetic (“PK”) characteristics and facilitate lower dosing requirements, bypass first-pass metabolism in certain cases, reduce side effects, and eliminate gastrointestinal interactions that limit bioavailability. The company's lead product candidate, TLANDO™, is an oral testosterone replacement therapy (“TRT”) and is currently under review by the United States Food and Drug Administration (“FDA”) with a Prescription Drug User Fee Act (“...

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...